IRIS iChemVELOCITY and iRICELL Urinalysis Workstation Now Available in U.S.

April 7th, 2011 Editors Pathology

IRIS International (Chatsworth, CA) has received FDA approval and started shipping the iChemVelocity Automated Urine Chemistry Analyzers along with the iRICELL Urinalysis Workstations.

The iChemVELOCITY Urine Chemistry System takes a leap forward with the development of an ascorbic acid test pad to identify possible ascorbic acid interference to insure clinically significant and accurate results.
The system utilizes iChem test strips which provide a twelve-test profile, including ten chemistry assays (Glucose, Protein, Bilirubin, Urobilinogen, pH, Blood Ketones, Nitrite, Leukocyte esterase, Ascorbic Acid), specific gravity by refractometer, color, and clarity.

Effortless operation, just load samples, press start, and walk away
210 samples per hour
Continuous strip loading capability
300 urine chemistry strip load capacity
10,000 Patient record storage capacity
Excellent low-end sensitivty
Utilization of ascorbic acid detection to prevent potential interference with key chemistry assays

Press release: IRIS International Begins U.S. Commercial Shipments of iChem(R)VELOCITY(TM) and iRICELL(R) Urinalysis Workstation in March Following Recent FDA 510(k) Clearance…
Product pages: iChemVELOCITY; iRICELL…

Upcoming conferences

october

18octallday19alldayWorld Congress on Polycystic Ovarian Syndrome and Fertility, 2018Abu Dhabi, UAE

18octallday19alldayManaging Your Complaints and Obstacles in Post-Market Requirements -- Results from Top Medical Device Observations During an InspectionMinneapolis, MN, USA

Event Details

Post-Market activities, Complaint Handling, MDRs, and Recalls are expensive, time consuming, and often lead to more serious financial consequences. Over 80% of FDA Inspection target observations for lack of compliance in these areas.

By attending this seminar, you will discover:

How to overcome one of the biggest obstacles device manufacturers face
How the FDA expects you to develop and implement proper handling of complaints reportable or non-reportable, product complaint handling and documentation
How and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall.
How to conduct a correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall and key factors in implementing and maintaining compliance with the regulations and real life experiences of FDA.

**New course materials have been added, updated content will include:

Creating Standard Operating Systems (SOPs) for Post-Market Quality Systems and
What to expect from the changes in ORA with Inspection Structure Realignment

This Seminar will have you stop spinning your wheels with nonessential activities, and leave you with a comprehensive learning package that only Rita Hoffman, a former FDA CDRH Recall Branch Chief with experience across the device, drug and veterinary industries can provide.

Spend one and a half days in an interactive course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief with over 36 years with FDA and leading Industry Expert, who will provide the participants with tools to minimize risk of regulatory enforcement actions.

Time

october 18 (Thursday) - 19 (Friday)

Organizer

Compliance Online 80068SEM

Learn More

Calendar GoogleCal

18octallday19allday18th Global Ophthalmology, Optometry and Glaucoma Conference, 2018Helsinki, Finland

18octallday19alldayBiology and Pathology of Infectious Disease Conference, 2018Helsinki, Finland

18octallday19allday14th Global Biomarkers Summit, 2018Amsterdam, Netherlands

22octallday23alldayInternational Conference on Breast Cancer, 2013Vancouver, British Columbia, Canada